HUP9902521A2 - Trombocitaaggregációt gátló piridinszármazékokat tartalmazó gyógyászati készítmények - Google Patents
Trombocitaaggregációt gátló piridinszármazékokat tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP9902521A2 HUP9902521A2 HU9902521A HUP9902521A HUP9902521A2 HU P9902521 A2 HUP9902521 A2 HU P9902521A2 HU 9902521 A HU9902521 A HU 9902521A HU P9902521 A HUP9902521 A HU P9902521A HU P9902521 A2 HUP9902521 A2 HU P9902521A2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- platelet aggregation
- piperidine derivatives
- aggregation inhibitors
- Prior art date
Links
- 229940127218 antiplatelet drug Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000007979 citrate buffer Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A találmány őlyan gyógyászati készítményekre vőnatkőzik, amelyekgátőlják a fibrinőgénkötődést trőmbőcitákhőz, és megakadályőzzák atrőmbőciták aggregációját, s ennek következtében a trőmbőcitákhalmőzódásából eredő kórős állapőtők kezelésére vagy megelőzésérealkalmazhatók. A készítmények hatóanyagai az (I) általánős képletűvegyületek és gyógyászati szempőntból elfőgadható sóik, ahől aképletben R4 jelentése arilcsőpőrt; 1-10 szénatőmős alkilcsőpőrt; vagy 1-10szénatőmős aril-alkil-csőpőrt; R5 jelentése -CO-R8 általánős képletű csőpőrt, amelyben R8 hidrőxil-vagy 1-10 szénatőmős alkőxicsőpőrtőt jelent; p értéke 0 vagy 1; és m értéke 2-től 6-ig terjedő egész szám -. A találmány szerintikészítmények a hatásős kőmpőnensen kívül egy citrátpűffer gyógyászatiszempőntból elfőgadható mennyiségét, valamint egy tőnicitást szabályzószer gyógyászati szempőntból elfőgadható mennyiségét tartalmazzák. Egykészítmény előnyös kiviteli alakja példáűl körülbelül 0,05-0,25 mg/ml2-S-(n-bűtil-szűlfőnil-aminő)-3-{4-[4-(piperidin-4-il)-bűtil-őxi]-fenil}-prőpiőnsavat, 2-20 mmől/l citrátpűffert és 290 milliőzmőltőnicitást szabályzó szert (példáűl nátriűm-klőridőt) tartalmaz, éspH-értéke körülbelül 6. ŕ
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US590795P | 1995-10-27 | 1995-10-27 | |
| GBGB9603721.3A GB9603721D0 (en) | 1996-02-22 | 1996-02-22 | Composition for inhibiting platelet aggregation |
| PCT/US1996/017193 WO1997015328A1 (en) | 1995-10-27 | 1996-10-23 | Pharmaceutical compositions containing platelet aggregation inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP9902521A2 true HUP9902521A2 (hu) | 1999-12-28 |
| HUP9902521A3 HUP9902521A3 (en) | 2000-01-28 |
| HU228757B1 HU228757B1 (en) | 2013-05-28 |
Family
ID=26308777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9902521A HU228757B1 (en) | 1995-10-27 | 1996-10-23 | Pharmaceutical compositions containing piperidine derivatives as platelet aggregation inhibitors |
Country Status (35)
| Country | Link |
|---|---|
| EP (1) | EP0859634B1 (hu) |
| JP (1) | JP3452367B2 (hu) |
| KR (1) | KR100362799B1 (hu) |
| CN (1) | CN1158107C (hu) |
| AT (1) | ATE213648T1 (hu) |
| AU (1) | AU712755B2 (hu) |
| BG (1) | BG63623B1 (hu) |
| BR (1) | BR9610878A (hu) |
| CA (1) | CA2234364C (hu) |
| CO (1) | CO4770960A1 (hu) |
| CY (1) | CY2292B1 (hu) |
| CZ (1) | CZ290381B6 (hu) |
| DE (1) | DE69619540T2 (hu) |
| DK (1) | DK0859634T3 (hu) |
| DZ (1) | DZ2110A1 (hu) |
| EA (1) | EA000628B1 (hu) |
| EE (1) | EE03518B1 (hu) |
| ES (1) | ES2171749T3 (hu) |
| HK (1) | HK1017846A1 (hu) |
| HU (1) | HU228757B1 (hu) |
| IL (1) | IL123790A (hu) |
| IS (1) | IS1948B (hu) |
| MX (1) | MX9803275A (hu) |
| MY (1) | MY116837A (hu) |
| NO (1) | NO324415B1 (hu) |
| NZ (1) | NZ323134A (hu) |
| PL (1) | PL185744B1 (hu) |
| PT (1) | PT859634E (hu) |
| SA (1) | SA96170527B1 (hu) |
| SI (1) | SI0859634T1 (hu) |
| SK (1) | SK282353B6 (hu) |
| TR (1) | TR199800716T2 (hu) |
| TW (1) | TW385248B (hu) |
| UA (1) | UA45423C2 (hu) |
| WO (1) | WO1997015328A1 (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ633900A0 (en) | 2000-03-20 | 2000-04-15 | Jurox Pty Ltd | Anaesthetic composition |
| CN1322863C (zh) * | 2004-10-29 | 2007-06-27 | 武汉远大制药集团股份有限公司 | 一种抑制血小板凝聚的注射液及其制备方法 |
| CN100386079C (zh) * | 2005-03-24 | 2008-05-07 | 武汉远大制药集团股份有限公司 | 一种抑制血小板凝聚的注射用粉针及其制备方法 |
| CN100367961C (zh) * | 2005-09-30 | 2008-02-13 | 天津南开允公医药科技有限公司 | 盐酸替罗非班冻干粉针注射剂及其制备方法 |
| CN102125519B (zh) * | 2011-02-28 | 2012-07-11 | 正大青春宝药业有限公司 | 稳定的盐酸替罗非班注射液及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4931441A (en) * | 1988-11-09 | 1990-06-05 | Luitpold Pharmaceuticals, Inc. | Stabilized aqueous leucovorin calcium compositions |
| NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
-
1996
- 1996-10-17 TW TW085112709A patent/TW385248B/zh not_active IP Right Cessation
- 1996-10-22 MY MYPI96004366A patent/MY116837A/en unknown
- 1996-10-23 JP JP51683897A patent/JP3452367B2/ja not_active Expired - Fee Related
- 1996-10-23 PL PL96326419A patent/PL185744B1/pl not_active IP Right Cessation
- 1996-10-23 DE DE69619540T patent/DE69619540T2/de not_active Expired - Lifetime
- 1996-10-23 CZ CZ19981278A patent/CZ290381B6/cs not_active IP Right Cessation
- 1996-10-23 AT AT96940256T patent/ATE213648T1/de active
- 1996-10-23 PT PT96940256T patent/PT859634E/pt unknown
- 1996-10-23 CN CNB961978775A patent/CN1158107C/zh not_active Expired - Lifetime
- 1996-10-23 SK SK512-98A patent/SK282353B6/sk not_active IP Right Cessation
- 1996-10-23 KR KR10-1998-0702957A patent/KR100362799B1/ko not_active IP Right Cessation
- 1996-10-23 EP EP96940256A patent/EP0859634B1/en not_active Expired - Lifetime
- 1996-10-23 EE EE9800134A patent/EE03518B1/xx not_active IP Right Cessation
- 1996-10-23 NZ NZ323134A patent/NZ323134A/xx not_active IP Right Cessation
- 1996-10-23 WO PCT/US1996/017193 patent/WO1997015328A1/en active IP Right Grant
- 1996-10-23 DK DK96940256T patent/DK0859634T3/da active
- 1996-10-23 TR TR1998/00716T patent/TR199800716T2/xx unknown
- 1996-10-23 IL IL12379096A patent/IL123790A/en not_active IP Right Cessation
- 1996-10-23 EA EA199800336A patent/EA000628B1/ru not_active IP Right Cessation
- 1996-10-23 UA UA98042034A patent/UA45423C2/uk unknown
- 1996-10-23 ES ES96940256T patent/ES2171749T3/es not_active Expired - Lifetime
- 1996-10-23 SI SI9630443T patent/SI0859634T1/xx unknown
- 1996-10-23 AU AU77189/96A patent/AU712755B2/en not_active Ceased
- 1996-10-23 CA CA002234364A patent/CA2234364C/en not_active Expired - Fee Related
- 1996-10-23 BR BR9610878A patent/BR9610878A/pt not_active IP Right Cessation
- 1996-10-23 HU HU9902521A patent/HU228757B1/hu unknown
- 1996-10-24 CO CO96056416A patent/CO4770960A1/es unknown
- 1996-10-26 DZ DZ960154A patent/DZ2110A1/fr active
- 1996-12-25 SA SA96170527A patent/SA96170527B1/ar unknown
-
1998
- 1998-03-24 IS IS4699A patent/IS1948B/is unknown
- 1998-04-24 NO NO19981869A patent/NO324415B1/no not_active IP Right Cessation
- 1998-04-24 MX MX9803275A patent/MX9803275A/es unknown
- 1998-04-24 BG BG102405A patent/BG63623B1/bg unknown
-
1999
- 1999-05-17 HK HK99102186A patent/HK1017846A1/xx not_active IP Right Cessation
-
2002
- 2002-08-23 CY CY0200051A patent/CY2292B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH23739A (en) | Piperidine derivative and pharmaceutical composition | |
| BG100154A (en) | Carbazole derivatibes having inhibiting effect to 17,20-lyase | |
| TW375615B (en) | Galanthamine derivatives and their use as medicaments | |
| BR9911300A (pt) | Composto, composição farmacêutica, e, uso do composto | |
| HUP9902521A2 (hu) | Trombocitaaggregációt gátló piridinszármazékokat tartalmazó gyógyászati készítmények | |
| MD522G2 (ro) | Noi derivaţi de piperidinii tioindol, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizare a lor ca analgezice | |
| GR3023444T3 (en) | Nitrogen containing bicyclic derivatives, method for their preparation and pharmaceutical compositions containing them | |
| KR920004402A (ko) | 신규 퀴놀린 카르복실산 유도체, 상기 화합물 함유 항균제 및 상기 화합물 제조 방법 | |
| BR0013375A (pt) | Composições farmacêuticas contendo derivados tiazolidinodiona e processo para sua preparação | |
| GB1312205A (en) | Method and composition for lowering blood pressure | |
| AP9901567A0 (en) | Steroids substituted in composition 11, their preparation process, their use as medicaments and the pharmaceutical compounds containing them. | |
| GB8515212D0 (en) | Thiazolidine derivatives | |
| ES8507524A1 (es) | Un procedimiento para preparar derivados de tropona | |
| ES8403916A1 (es) | Un procedimiento para la preparacion de un derivado de b -lactama. | |
| ES450364A1 (es) | Procedimiento para preparar compuestos de bis-biguanida. | |
| ES8302670A1 (es) | Procedimiento de preparacion de nuevos derivados 2-hidroxi- metil-quinoxalino-1,4-dioxidos | |
| ATE21908T1 (de) | Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| TH8005B (th) | องค์ประกอบสำหรับใช้ทางปาก (Oral Composition) | |
| GB1463965A (en) | Pharmaceutical compositions containing benzylamines | |
| GB1504207A (en) | Compositions containing p-alkanoyltoluene derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: IROKO CARDIO LLC, US Free format text: FORMER OWNER(S): MERCK & CO., INC., US |